An Open-Label Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderate to Severe Ulcerative Colitis.
Phase of Trial: Phase II
Latest Information Update: 21 Dec 2017
At a glance
- Drugs BL 7040 (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors BioLineRx
- 29 Aug 2016 Results assessing efficacy,safety and tolerability published in the Digestive Diseases and Sciences (2016).
- 26 Nov 2013 Additional results reported in a BioLineRx media release.
- 17 Apr 2013 Status changed from active, no longer recruiting to completed, according to a BioLineRx media release.